Skip to content

The Application of a Rapid Assessment Strategy Based on the ROX Index in the Withdrawal of High-Flow Nasal Oxygen Therapy

The Application of a Rapid Assessment Strategy Based on the ROX Index in the Withdrawal of High-Flow Nasal Oxygen Therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095412
Enrollment
Unknown
Registered
2025-01-07
Start date
2025-01-15
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure

Interventions

Quick Reduction Flow Group:Directly reduce HFNC flow rate from 40 L/min to 20 L/min
Gradual Decrease Flow Group:Reduce the HFNC flow rate by 5 L/min per hour.

Sponsors

Suzhou Hospital of Anhui Medical University (Suzhou Municipal Hospital of Anhui Province)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old; 2. Patients with acute hypoxic respiratory failure; Stay in intensive care unit (ICU) for >=72 hours; 3. 4. Informed consent has been obtained.

Exclusion criteria

Exclusion criteria: 1. End-stage maintenance patients; Patients with acute heart failure; 2. 3. Acute exacerbation of chronic obstructive pulmonary disease with type II respiratory failure; 4. Sequential treatment of patients after mechanical ventilation; 5. Other patients who do not meet the indications for HFNC.

Design outcomes

Primary

MeasureTime frame
Duration of HFNC application;ICU length of stay (LOS);Length of stay in hospital;Primary clinical outcomes;

Secondary

MeasureTime frame
Heart rate;Blood pressure;Respiratory rate;Peripheral capillary oxygen saturation;Fraction of Inspired Oxygen;Arterial oxygen partial pressure;Arterial carbon dioxide partial pressure;

Countries

China

Contacts

Public ContactYaguang Wu

Suzhou Hospital of Anhui Medical University (Suzhou Municipal Hospital of Anhui Province)

wuyaguang@ahmu.edu.cn+86 185 0557 5711

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026